KINGFA NSI Week ended 07 Aug 2026

Weekly Investor Report

Kingfa Science & Technology (India) Limited · Basic Materials · Specialty Chemicals

Latest close 5,550 INR
5.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 17.1% above the Trend Line and sits at 93.3% of its 52-week range. The latest completed week returned 5.7%, after a 7.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high.

Setup score 74 out of 100
Latest Close 5,550 INR 7 Aug 2026
1W Return 5.7% latest completed week
4W Return 7.8% short-term follow-through
12W Return 7.2% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 2.9x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 5 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.1% above the Trend Line and sits at 93.3% of its 52-week range. The latest completed week returned 5.7%, after a 7.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8712-week average 0.85

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.8% over four weeks, 7.2% over 12 weeks, and 59.3% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W5.7%
4W7.8%
12W7.2%
26W30.2%
52W59.3%
Active trend streak14 weeks
Active weeks in one year41
Trend breadth78.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.04Latest activity-pressure read.
Pressure change-107.2%Four-week change in activity pressure.
Leadership21.98Latest relative-leadership reading.
RS change17.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality37/100Profitability and accounting quality. Underlying universe rank 64; rank 1 is best.
Momentum92/100Medium-term price momentum. Underlying universe rank 9; rank 1 is best.
Growth61/100Revenue and earnings growth. Underlying universe rank 40; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework60/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
40.6x
Price divided by trailing earnings.
Price / sales
3.8x
Market value relative to trailing revenue.
EV / EBITDA
26.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
23.9%
Gross profit retained from each unit of revenue.
Operating margin
16.3%
Operating profit retained from revenue.
Free-cash-flow margin
-2.3%
Free cash flow generated from revenue.
Return on invested capital
19.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.4%
Latest one-year revenue growth.
EPS growth
8.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-252.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-6.6%
Net share repurchases relative to market value.
Shareholder yield
-6.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 20 relevant articles.

3 positive · 17 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.6%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+12.5%Week of 8 May.
Worst week-6.0%Week of 20 Feb.
Latest week+5.7%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.3%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew5.5% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20265,550 INR5.7%4,739 INR3,313 INR-0.0421.9879.0KOn
31 Jul 20265,248 INR0.7%4,699 INR3,293 INR-0.0517.2644.7KOn
24 Jul 20265,212 INR3.5%4,672 INR3,274 INR0.0820.5325.3KOn
17 Jul 20265,038 INR-2.1%4,636 INR3,255 INR0.2514.6721.2KOn
10 Jul 20265,146 INR0.7%4,602 INR3,235 INR0.5218.6848.5KOn
3 Jul 20265,108 INR1.0%4,559 INR3,214 INR0.5618.454.2KOn
26 Jun 20265,059 INR-1.9%4,520 INR3,194 INR0.7319.340On
19 Jun 20265,160 INR1.0%4,501 INR3,175 INR1.0823.016.3KOn
12 Jun 20265,108 INR-4.8%4,463 INR3,154 INR1.1925.072.2KOn
5 Jun 20265,367 INR-1.9%4,435 INR3,134 INR1.3834.203.8KOn
29 May 20265,473 INR6.6%4,406 INR3,112 INR1.5837.3759.8KOn
22 May 20265,136 INR-0.8%4,378 INR3,090 INR1.5429.3329.3KOn
15 May 20265,177 INR-3.7%4,361 INR3,070 INR1.6532.0533.7KOn
8 May 20265,375 INR12.5%4,346 INR3,048 INR1.5735.5073.1KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context